LUMAKRAS

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark LUMAKRAS was filed as Word mark on 01/04/2021 at the World Intellectual Property Organization.

Trademark Details Last update: March 8, 2023

Trademark form Word mark
File reference 1577929
Countries Afghanistan Albania Armenia Azerbaijan Bosnia and Herzegovina Bahrain Bonaire, Sint Eustatius and Saba Botswana Belarus Curacao Algeria Egypt Georgia Indonesia Israel Iran Kenya Kyrgyzstan Kazakhstan Liechtenstein Morocco Monaco Moldova Montenegro Macedonia Malaysia Oman Philippines Serbia Sudan Sint Maarten Thailand Tajikistan Turkmenistan Uzbekistan Vietnam
Base trademark US No. 90044720, July 9, 2020
Application date January 4, 2021
Expiration date January 4, 2031

Trademark owner

Trademark Operations MS 28-5-A
One Amgen Center Drive
US

Trademark representatives

One Amgen Center Drive Trademark Operations-MS-28-5A US

goods and services

05 Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

Trademark history

Date Document number Area Entry
February 17, 2023 2023/10 Gaz TH Rejection
October 28, 2022 2022/44 Gaz MY Rejection
August 10, 2022 2022/32 Gaz TM Rejection
June 20, 2022 2022/32 Gaz PH RAW: Rule 18ter(2)(i) GP following a provisional refusal
April 12, 2022 2022/15 Gaz BA Rejection
March 9, 2022 2022/10 Gaz ID Rejection
March 9, 2022 2022/13 Gaz US RAW: Partial Ceasing Effect
February 22, 2022 2022/8 Gaz LI Rejection
February 22, 2022 2022/8 Gaz VN Rejection
February 15, 2022 2022/7 Gaz BW Rejection
January 28, 2022 2022/5 Gaz GE Rejection
January 25, 2022 2022/4 Gaz ME Rejection
January 14, 2022 2022/3 Gaz MD Rejection
November 17, 2021 2021/46 Gaz MC Rejection
November 9, 2021 2021/45 Gaz SX Rejection
November 5, 2021 2021/45 Gaz TJ Rejection
November 2, 2021 2021/44 Gaz KG Rejection
November 2, 2021 2021/44 Gaz KZ Rejection
October 21, 2021 2021/42 Gaz DZ Rejection
October 4, 2021 2021/40 Gaz IL Rejection
October 4, 2021 2021/40 Gaz CW Rejection
September 2, 2021 2021/36 Gaz BY Rejection
August 12, 2021 2021/33 Gaz RS Rejection
March 21, 2021 2021/13 Gaz PH Rejection
January 4, 2021 2021/6 Gaz US Registration

ID: 141577929